Curanex Pharmaceuticals (CURX) is trading up at $4.95 (+0.68%), as of the latest quote. It operates in the Health Care sector.
| FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|
| Income statement | ||
| Operating income | −$365.1K | −$4.24M |
| Net income | −$361.5K | −$4.23M |
| EPS (diluted) | −$0.03 | −$0.17 |
| Balance sheet | ||
| Cash and equivalents | $148.9K | $5.00M |
| Total assets | $517.9K | $11.6M |
| Total liabilities | $14.6K | $361.0K |
| Shareholders' equity | $503.4K | $11.2M |
| Cash flow | ||
| Operating cash flow | −$555.6K | −$10.5M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$93.3K | −$147.4K | −$137.5K | −$57.7K | −$951.3K | −$3.09M | −$3.18M | −$3.33M |
| Net income | −$91.2K | −$145.9K | −$137.6K | −$60.3K | −$954.1K | −$3.07M | −$3.15M | −$3.29M |
| EPS (diluted) | −$0.04 | $0.06 | −$0.01 | $0.00 | −$0.04 | −$0.12 | −$0.11 | −$0.12 |
| Balance sheet | ||||||||
| Cash and equivalents | — | $148.9K | — | $108.9K | $5.80M | $5.00M | $4.00M | $2.94M |
| Total assets | — | $517.9K | — | $787.2K | $14.5M | $11.6M | $8.41M | $5.07M |
| Total liabilities | — | $14.6K | — | $481.7K | $186.0K | $361.0K | $332.6K | $286.3K |
| Shareholders' equity | $624.2K | $503.4K | $365.8K | $305.4K | $14.3M | $11.2M | $8.08M | $4.79M |
| Cash flow | ||||||||
| Operating cash flow | −$129.9K | −$95.4K | −$149.9K | −$290.1K | −$9.19M | −$857.4K | −$954.6K | −$1.08M |
From Curanex Pharmaceuticals's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Curanex Pharmaceuticals in our feed yet.